Hear new research from Tufts Center for the Study of Drug Development on current and evolving EDC practices across the drug development enterprise. Richard Young, vice president of Veeva Vault EDC at Veeva Systems will share how core functions will be impacted by the expansion of personalized medicine, adaptive trials, new regulations, and the continued evolution of business practices.

Read the survey report here.